Cargando…
Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial
SIMPLE SUMMARY: This study was a retrospective investigation of a Japanese cohort of 205 metastatic castration-resistant prostate cancer (mCRPC) patients who received Ra-223 in 14 hospitals between July 2016 and August 2020 and for whom bone scintigraphy before and after the radium-223 treatment was...
Autores principales: | Kitajima, Kazuhiro, Kuyama, Junpei, Kawahara, Takashi, Suga, Tsuyoshi, Otani, Tomoaki, Sugawara, Shigeyasu, Kono, Yumiko, Tamaki, Yukihisa, Seko-Nitta, Ayumi, Ishiwata, Yoshinobu, Ito, Kimiteru, Toriihara, Akira, Watanabe, Shiro, Hosono, Makoto, Miyake, Hideaki, Yamamoto, Shingo, Sasaki, Ryohei, Narita, Mitsuhiro, Yamakado, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216679/ https://www.ncbi.nlm.nih.gov/pubmed/37345121 http://dx.doi.org/10.3390/cancers15102784 |
Ejemplares similares
-
Introduction of the targeted alpha therapy (with Radium-223) into clinical practice in Japan: learnings and implementation
por: Hosono, Makoto, et al.
Publicado: (2018) -
Radium-223 and concomitant therapies: prospects and prudence
por: Yeku, Oladapo, et al.
Publicado: (2016) -
Radium 223 dichloride for prostate cancer treatment
por: Deshayes, Emmanuel, et al.
Publicado: (2017) -
The Potential Use of 11C-Choline Positron Emission Tomography/Computed Tomography to Monitor the Treatment Effects of Radium-223 in a Patient with Prostate Cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2018) -
Radium-223 in metastatic castration resistant prostate cancer
por: Vuong, Winston, et al.
Publicado: (2014)